Farther Finance Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4K Buy
784
+531
+210% +$5.12K ﹤0.01% 4336
2026
Q1
$1.96K Sell
253
-206
-45% -$2.17K ﹤0.01% 4908
2025
Q4
$5.4K Buy
459
+128
+39% +$1.38K ﹤0.01% 4267
2025
Q3
$2.56K Buy
331
+120
+57% +$841 ﹤0.01% 4046
2025
Q2
$1.54K Sell
211
-16
-7% -$129 ﹤0.01% 3781
2025
Q1
$2.12K Buy
227
+168
+285% +$2.1K ﹤0.01% 3367
2024
Q4
$972 Sell
59
-11
-16% -$171 ﹤0.01% 3258
2024
Q3
$1.03K Sell
70
-81
-54% -$1.27K ﹤0.01% 3234
2024
Q2
$2.1K Buy
151
+88
+140% +$1.25K ﹤0.01% 2774
2024
Q1
$970 Sell
63
-147
-70% -$2.27K ﹤0.01% 2790
2023
Q4
$3.4K Buy
210
+182
+650% +$2.98K ﹤0.01% 2172
2023
Q3
$344 Hold
28
﹤0.01% 2354
2023
Q2
$450 Hold
28
﹤0.01% 2180
2023
Q1
$487 Hold
28
﹤0.01% 2013
2022
Q4
$259 Buy
+28
New +$261 ﹤0.01% 1978

Other funds holding NEO

Farther Finance Advisors's NEO Position: Q2 2026 in Review

Farther Finance Advisors increased its NeoGenomics (NEO) stake by 210% in Q2 2026, buying an estimated $5.12K and bringing the position to 784 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4336.

Farther Finance Advisors first reported a position in NEO in Q4 2022 and has held it in 15 quarters since. 37 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Farther Finance Advisors held 784 shares of NeoGenomics worth $11.4K as of Q2 2026.
  • Farther Finance Advisors bought 531 NeoGenomics shares in Q2 2026, an estimated $5.12K.
  • NeoGenomics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4336 holding.
  • Farther Finance Advisors first reported a position in NeoGenomics in Q4 2022 and has held it in 15 quarters since.
  • 37 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.